tffpharma.com (TFFP): Net earnings per share growth forecast for next year
TFF Pharmaceuticals is currently undergoing full liquidation due to a capital deficit. The forward-looking net earnings per share growth exhibits a prolonged sideways trend, where 0.00 determines the latest valuation metric. TFF Pharmaceuticals developed a B2B platform for creating inhalation powders, but faced severe pressure from pharmaceutical behemoths seeking to monopolize drug delivery systems.
tffpharma.com (TFFP) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
Total Debt to Capital TFF Pharmaceuticals|TFFP - Long-Term Liabilities to Equity|Short-Term Debt to Equity Ratio TFF Pharmaceuticals, Inc.|TFFP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio TFF Pharmaceuticals|TFFP - Long-Term Liabilities|Company Short-Term Debts TFF Pharmaceuticals|Quick Ratio tffpharma.com
- earnings and market ratios statistics:
TFFP - Net Profit|Expected Profit TFF Pharmaceuticals|TFFP - Company Value to Net Income|Future Price to Earnings TFF Pharmaceuticals|TFFP - Price/Earnings to Growth Multiple|EV/EBITDA Multiple TFF Pharmaceuticals|TFFP - Operating profit EBITDA|Net earnings per share (EPS TTM) TFF Pharmaceuticals|TFFP - Net earnings per share for the last 12 months|Quarterly EPS earnings growth tffpharma.com|TFFP - Earnings per share growth rate in current year|Expected earnings per share growth for next year TFF Pharmaceuticals
- sales volume and revenue information:
Fundamental company valuation:TFFP, TFF Pharma
This indicator measures the expected value of profit growth rates for the coming period, reflecting the sensitivity of cash flows to market forecasts and the quality of capital management. Amid the liquidation of TFF Pharmaceuticals (TFFP) and the loss of its technological platform, the downward trend of the forward net income metric confirms a total loss of investment attractiveness and the inevitability of asset impairment.
Who TFF Pharmaceuticals competes with
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Ligand - Expected earnings per share growth for next year|Projected earnings per share increase next year AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company - Earnings growth forecast for next year|Net earnings per share change forecast for next year ALVO|LQDA: Earnings growth forecast for next year|Net earnings per share change forecast for next year GLPG (glpg.com)|Expected earnings per share growth for next year ANIP|MNKD: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Amphastar (AMPH)|PCRX: Net earnings per share change forecast for next year|Earnings growth forecast for next year SPRY (ARS Pharmaceuticals)|Expected earnings per share trend next year TBPH|Aquestive Therapeutics, Inc. - Earnings growth forecast for next year|SCPH - Earnings growth forecast for next year|tectonictx.com (TECX) - Net earnings per share growth forecast for next year|Tonix Pharmaceuticals Holding - Expected earnings per share trend next year|Net earnings per share growth forecast for next year SXT Pharmaceuticals|Expected earnings per share growth for next year Eupraxia Pharma (EPRX)|Earnings growth forecast for next year BHST|Earnings growth forecast for next year Invizyne Technologies (EXOZ)|Earnings growth forecast for next year ORMP (Oramed Pharmaceuticals Inc.)|ENTX - Expected earnings per share growth for next year|MindWalk Holdings - Earnings growth forecast for next year|Expected net earnings per share growth next year abvcpharma.com|CPIX (Cumberland Pharmaceuticals Inc.) - Expected earnings per share growth for next year|Quantum BioPharma Ltd. (QNTM) - Earnings growth forecast for next year|Expected earnings per share growth for next year FGEN|TELO (Telomir Pharmaceuticals Corp) - Projected earnings per share increase next year|Earnings growth forecast for next year RANI|Consensus forecast of earnings per share growth for next year synergychc.com|Earnings growth forecast for next year RLYB (Rallybio)|LEXX - Expected earnings per share growth for next year|Pulmatrix Corp - Earnings growth forecast for next year|PTHL - Earnings growth forecast for next year|aptorumgroup.com (APM) - Net earnings per share growth forecast for next year|LYRA (lyratherapeutics.com) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Impact BioMedical Inc|TNF Pharma (TNFA) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year YCBD (cbdMD, Inc.)|Projected earnings per share increase next year PRFX|Earnings growth forecast for next year CYTO (Altamira Therapeutics Ltd.)|LIPO (lipella.com) - Net earnings per share change forecast for next year|OptiNose - Earnings growth forecast for next year|Net earnings per share change forecast for next year PIRS|Procaps Group SA (PROC) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PTPI (Petros Pharma)|Net earnings per share growth forecast for next year Qilian International|acelyrin.com - Net earnings per share change forecast for next year
